As of July 14, 2026, a total of 2,093 confirmed cases of Bundibugyo virus disease (BVD) and 798 deaths have been reported in the Democratic Republic of the Congo (DRC) and Uganda, according to the latest situation report from the World Health Organization (WHO). A total of 394 people have recovered from the illness.
In the latest 24-hour period, the DRC reported 62 new cases and 42 deaths, primarily in the Ituri province. The outbreak, which began in late 2025, has been concentrated in remote areas with limited healthcare access.
Bundibugyo virus is a species of ebolavirus first identified in Uganda in 2007. Symptoms include fever, fatigue, muscle pain, headache, and sore throat, followed by vomiting, diarrhea, rash, and in severe cases, internal and external bleeding. The case fatality rate in this outbreak is approximately 38%.
Health authorities, with support from WHO and other partners, are conducting contact tracing, community surveillance, and vaccination campaigns using an experimental vaccine. Challenges include insecurity in some affected regions and community mistrust.
The WHO has not declared this a Public Health Emergency of International Concern, but continues to monitor the situation closely. Neighboring countries have been advised to strengthen surveillance.
